Objective To investigate the risk factors for variceal rebleeding after esophagogastric devascularization and splenectomy in patients with portal hypertension. Methods A retrospective analysis was performed for the clinical data of 244 patients with portal hypertension who were admitted to Beijing YouAn Hospital from April 2010 to September 2015 and underwent esophagogastric devascularization and splenectomy. According to the presence or absence of variceal rebleeding, these patients were divided into non-rebleeding group and rebleeding group. Preoperative, intraoperative, and postoperative clinical data were compared between the two groups. The t-test was used for comparison of normally distributed continuous data between groups, and the Wilcoxon rank-sum test was used for comparison of non-normally distributed data between groups; the chi-square test was used for comparison of categorical data between groups. A multivariate logistic regression analysis was performed for statistically significant variables identified by the univariate analysis. Results Of all 244 patients, 38 ( 15. 6%) experienced variceal rebleeding. The univariate analysis showed that there were significant differences between the two groups in the history of variceal bleeding, preoperative ascites, total bilirubin after surgery, portal venous pressure after devascularization, portal venous pressure before and after splenectomy, and preoperative international normalized ratio ( χ2= 5. 530、4. 120, t = 3. 591、4. 098、2. 516、2. 622、4. 278, P = 0. 016, 0. 026, 0. 008, 0. 002, 0. 022, 0. 012, and 0. 003) . The multivariate logistic regression analysis showed that variceal rebleeding after esophagogastric devascularization and splenectomy was associated with the history of variceal bleeding ( 95% CI:1. 113-13. 704, P = 0. 033) , preoperative ascites ( 95% CI: 1. 257-5. 437, P = 0. 010) , and portal venous pressure after devascularization ( 95% CI: 1. 022-1. 172, P = 0. 010) . Conclusion History of variceal bleeding, preoperative ascites, and portal venous pressure after devascularization are independent risk factors for variceal rebleeding after esophagogastric devascularization and splenectomy.
[1]ZHOU GW.The choice of surgical module for the treatment of portal hypertension in the era of liver transplantation[J].Chin J Bases Clin General Surg, 2013, 20 (1) :10-12. (in Chinese) 周光文.肝移植时代门静脉高压症外科手术方式的选择[J].中国普外基础与临床杂志, 2013, 20 (1) :10-12.
|
[2]WEN JS, YUE K, WU ZQ, et al.Comparative clinical analysis of three surgical methods in patients with cirrhotic portal hypertension complicated by upper gastrointestinal bleeding[J].J Clin Hepatol, 2016, 32 (2) :264-268. (in Chinese) 温建生, 岳琨, 吴智群, 等.肝硬化门静脉高压并发上消化道出血的3种手术方式比较分析[J].临床肝胆病杂志, 2016, 32 (2) :264-268.
|
[3]YANG Z.Current status and perspectives of surgical treatment of portal hypertension[J].J Clin Hepatol, 2016, 32 (2) :250-253. (in Chinese) 杨镇.我国门静脉高压症外科治疗的现况和展望[J].临床肝胆病杂志, 2016, 32 (2) :250-253.
|
[4]BAO HK, WEI XL.Comparisons of clinical effect of hand-assisted laparoscopic and open splenectomy combined with pericardial devascularization for the treatment of portal hypertension in liver cirrhosis[J].Chin J Med Offic, 2016, 44 (1) :92-94, 97. (in Chinese) 包汉康, 韦秀丽.手助腹腔镜与开腹脾切除贲门周围血管离断术治疗肝硬化门脉高压症的疗效比较[J].临床军医杂志, 2016, 44 (1) :92-94, 97.
|
[5]WANG M, WEN TF, YAN LN, et al.Comparison on effects of liver transplantation and periesophagogastric devascularization with splenectomy for portal hypertension and cir rhosis with liver function of Child Grade A[J].Chin J Bases Clin General Surg, 2013, 20:18-23.
|
[6]WU S, WU Z, ZHANG X, et al.The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization[J].Turk J Gastroenterol, 2015, 26 (5) :423-428.
|
[7]VOROS D, POLYDOROU A, POLYMENEAS G, et al.Longterm results with the modifed Sugiura procedure for the management of variceal bleeding:Standing the test of time in the treatment of bleeding esophageal varices[J].World J Surg, 2012, 36:659-666.
|
[8]MICHAEL HENDERSON J.Surgical treatment of portal hypertension[J].Baillière's Clin Gastroenterol, 2000, 14 (4) :911-925.
|
[9]DAGENAIS M, LANGER B, TAYLOR BR, et al.Experience with radical esophagogastric devascularization procedures (Sugiura) for variceal bleeding outside Japan[J].World J Surg, 1994, 18:222-228.
|
[10]MA XX, LI TX, WANG ZW, et al.Treatment strategy for upper gastrointestinal rebleeding after devascularization operation in portal hypertension patients:A report of 56 cases[J].Chin J Gen Surg, 2007, 16 (4) :353-355. (in Chinese) 马秀现, 李天晓, 王志伟, 等.门静脉高压断流术后上消化道再出血的治疗策略:附56例报告[J].中国普通外科杂志, 2007, 16 (4) :353-355.
|
1. | 路燕,陈明月,郑秀良,雷宇. 185例药物性肝损伤患者的临床特征分析. 安徽医学. 2022(03): 308-313 . ![]() | |
2. | 赵临潇,左博云,李静亚,于东升. 妊娠期肝内胆汁淤积症孕妇胎盘ABCB4基因表达与妊娠结局的关系. 海南医学. 2022(11): 1424-1427 . ![]() | |
3. | 张慧芳,王高莹,邹萍,王晶,董蕊锐,张婷,孟西娜. 妊娠期肝内胆汁淤积症血清甘胆酸水平与妊娠结局的关系. 中国临床研究. 2022(06): 793-796 . ![]() | |
4. | 林洪萍,黄晋萍,黄淑兰,卢君,黎春,杨佳柳. 中药外洗在妊娠期肝内胆汁淤积症诱发皮肤瘙痒患者中的应用. 中国医学创新. 2022(19): 96-99 . ![]() | |
5. | 李媛,郑泽玉,田阗,邬洪明,田嫣然,李茂. 妊娠期肝内胆汁淤积症的危险因素分析. 临床和实验医学杂志. 2021(02): 200-203 . ![]() | |
6. | 段兴平,王燕,黄常友,郑会贤,罗一,覃正文,任郁. 妊娠期肝病的临床特征及研究进展. 临床肝胆病杂志. 2020(06): 1407-1411 . ![]() | |
7. | 陈韵洁,张晨,谭娟. 脂肪酸转运体蛋白FATP4、CD36、FABP1在妊娠期肝内胆汁淤积胎盘中表达研究. 中外医疗. 2020(15): 30-31+46 . ![]() | |
8. | 唐照青,俞海珍. 联合监护评估对妊娠期无症状高胆汁酸血症孕妇围生儿预后的价值. 中国现代药物应用. 2020(18): 19-22 . ![]() | |
9. | 汪学耀,张涛,荆成宝. 血清总胆汁酸与甘胆酸水平诊断妊娠期肝内胆汁淤积症能力的Meta分析. 现代检验医学杂志. 2020(05): 73-76 . ![]() | |
10. | 吕玉清. 我院中药处方中妊娠患者疾病及用药情况分析研究. 海峡药学. 2020(10): 176-178 . ![]() | |
11. | 刘燕,王丽娟,李盈盈. 综合护理在妊娠期肝内胆汁淤积症患者中的临床效果分析. 妇产与遗传(电子版). 2020(03): 40-44 . ![]() | |
12. | 张燕,王伟红. 妊娠期肝内胆汁淤积症孕妇血清总胆汁酸、谷草转氨酶及Th17/Treg平衡水平及临床意义. 中国计划生育学杂志. 2020(12): 2093-2097 . ![]() | |
13. | 马艳辉,邵久玲,王双梅. 低分子肝素治疗妊娠期肝内胆汁淤积症的疗效及对肝胆指标、母婴结局的影响. 哈尔滨医药. 2020(05): 438-440 . ![]() |